Studies have found that CyPA inhibitors-alisporivir can inhibit the replication of the SARS-CoVs and the Middle East respiratory syndrome (MERS), and ribavirin enhances the anti-viral activity of alisporivir [15]. Here, PPIA is linked to Middle East respiratory syndrome.